Eastman Chemical Company (EMN) — Fair Value Analysis

Base-case fair value (P50): $77.51 · Current price: $73.25 · Verdict: Fairly Valued

The Verdict on EMN

Based on our proprietary Monte Carlo simulations, EASTMAN CHEMICAL (EMN) appears Fairly Valued at its current market price of $73.25. Our analysis indicates a median fair value (P50) of $77.51, suggesting a modest +5.8% upside from current levels. While this potential upside is present, it aligns with a "Fairly Valued" assessment given the inherent volatility and range of outcomes in such simulations. EMN’s average quality tier, reflecting its operational and financial health compared to its sector peers, supports this balanced view, implying that the current price adequately captures its fundamental strengths and weaknesses.

How EMN stacks up against peers

EMN’s average quality tier suggests that its operational and financial health falls in line with, rather than significantly above or below, its industry peers. This positioning is reflected in our fair value assessment, where the $77.51 points to a reasonable valuation relative to its current price of $73.25. While some companies might offer a larger +5.8% based on their quality tier and sector positioning, EMN's average standing means our models incorporate a typical risk-reward profile. Both upside and downside scenarios were rigorously modeled, but the median outcome points to a balanced current valuation, avoiding extremes of over or undervaluation.

What this means for investors

For investors considering EMN, the Fairly Valued verdict, coupled with an average quality tier, suggests that the market is currently pricing in the company's fundamentals effectively. The +5.8% to our median fair value of $77.51 from the current $73.25 indicates that significant alpha from a valuation arbitrage perspective may be limited without new catalysts. While a bull case scenario could unlock greater value, the average quality tier implies a balanced risk profile. For a complete picture, sign up for FairCurve to see the full Monte Carlo distribution, including bear and bull targets, and track EMN's fair value as new fundamentals are released.